The Patent Finder
US

Anti-Cancer Nuclear Hormone Receptor-Targeting Compounds

US 11,826,430 In force
OverviewFamilyAssignmentsSources & methods

Term ends May 29, 2041 · High confidence

Filed May 13, 2020 as application 15/931,495 · Granted Nov 28, 2023
Base term plus 381 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2020 2041
Clock starts
May 13, 2020
Term ends
May 29, 2041
Granted
Nov 28, 2023
base term patent term adjustment Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
381
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 381 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 13, 2020, when this application, 15/931,495, was filedMay 13, 2040High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+381 days, USPTO patent term adjustment recordMay 29, 2041High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 29, 2041High confidence

This family

US 11,826,430this patent
May 2041
May 2041
US 12,208,141In force
May 2040
May 2040
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 19, 2020
Reel 53539, frame 605
Pettigrew, Jeremy D.Sparcbio LLCAssignment of Assignor's Interest
Aug 25, 2020
Reel 53742, frame 442
Barde, Anup; Nayak, Anjan KumarIntegral Biosciences PVT. Ltd.Assignment of Assignor's Interest
Aug 25, 2020
Reel 54218, frame 315
Integral Biosciences PVT. Ltd.Sparcbio LLCAssignment of Assignor's Interest
Aug 25, 2020
Reel 53593, frame 839
Pham, Son Minh; Chakravarty, Sarvajit; Chen, Jiyun; Kankanala, JayakanthSparcbio LLCAssignment of Assignor's Interest
Aug 25, 2020
Reel 53593, frame 859
Sparcbio LLCNuvation Bio Inc.Assignment of Assignor's Interest
Aug 25, 2020
Reel 53593, frame 893
Hung, DavidNuvation Bio Inc.Assignment of Assignor's Interest
Mar 4, 2025
Reel 70400, frame 200
Nuvation Bio Inc.Sagard Holdings Manager LP, as Administrative AgentSecurity Interest
Jul 6, 2026
Reel 75179, frame 564
Sagard Holdings Manager LP, as Administrative AgentNuvation Bio Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited